Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol

被引:38
作者
Abate, G [1 ]
Miörner, H [1 ]
机构
[1] Statens Serum Inst, Dept Mycobacteriol, DK-2300 Copenhagen, Denmark
关键词
D O I
10.1093/jac/42.6.735
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Thirty clinical isolates of Mycobacterium tuberculosis, 20 of which were multidrug-resistant (MDR), were tested for susceptibility to different combinations of amoxycillin, clavulanic acid and subinhibitory concentrations of ethambutol. beta-Lactamase production was assessed semiquantitatively with the nitrocefin method and susceptibility testing was performed with the BACTEC method. All isolates were beta-lactamase positive and were resistant to 16 mg/L amoxycillin. The MIC of amoxycillin in combination with clavulanic acid was greater than or equal to 2 mg/L for 27/30 (90%) isolates. Addition of subinhibitory concentrations of ethambutol significantly reduced the MIC of amoxycillin for all tested isolates. Twenty-nine (97%) isolates had an MIC of amoxycillin of less than or equal to 0.5 mg/L when subinhibitory concentrations of ethambutol were added; this is well below the concentrations achievable in serum and tissue.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 23 条
[1]   Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime [J].
Abate, G ;
Hoffner, SE .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 28 (03) :119-122
[2]  
BRAGA PC, 1985, INT J CLIN PHARM RES, V5, P331
[3]   LEVELS OF ERYTHROMYCIN IN PULMONARY TISSUE AND BRONCHIAL MUCUS COMPARED TO THOSE OF AMOXYCILLIN [J].
BRUN, Y ;
FOREY, F ;
GAMONDES, JP ;
TEBIB, A ;
BRUNE, J ;
FLEURETTE, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 (06) :459-466
[4]   CAN PENICILLINS AND OTHER BETA-LACTAM ANTIBIOTICS BE USED TO TREAT TUBERCULOSIS [J].
CHAMBERS, HF ;
MOREAU, D ;
YAJKO, D ;
MIICK, C ;
WAGNER, C ;
HACKBARTH, C ;
KOCAGOZ, S ;
ROSENBERG, E ;
HADLEY, WK ;
NIKAIDO, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2620-2624
[5]   Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J].
Cohn, DL ;
Bustreo, F ;
Raviglione, MC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S121-S130
[6]  
DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213
[7]   Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis [J].
Herbert, D ;
Paramasivan, CN ;
Venkatesan, P ;
Kubendiran, G ;
Prabhakar, R ;
Mitchison, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2296-2299
[8]  
Hoffner S E, 1989, Acta Leprol, V7 Suppl 1, P195
[9]   SYNERGISTIC EFFECTS OF ANTIMYCOBACTERIAL DRUG-COMBINATIONS ON MYCOBACTERIUM-AVIUM COMPLEX DETERMINED RADIOMETRICALLY IN LIQUID-MEDIUM [J].
HOFFNER, SE ;
SVENSON, SB ;
KALLENIUS, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (05) :530-535
[10]   SUSCEPTIBILITY OF MYCOBACTERIUM-MALMOENSE TO ANTIBACTERIAL DRUGS AND DRUG-COMBINATIONS [J].
HOFFNER, SE ;
HJELM, U ;
KALLENIUS, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1285-1288